The Involvement of Long Non-Coding RNAs in Glioma: From Early Detection to Immunotherapy

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 May 27

PMID 35619711

Authors

Xiaoben Wu

Lei Yang

Jing Wang

Yingying Hao

Changyin Wang

Zhiming Lu

Affiliations

Soon will be listed here.

Abstract

Glioma is a brain tumor that arises in the central nervous system and is categorized according to histology and molecular genetic characteristics. Long non-coding RNAs (lncRNAs) are RNAs longer than 200 nucleotides in length. They have been reported to influence significant events such as carcinogenesis, progression, and increased treatment resistance on glioma cells. Long non-coding RNAs promote cell proliferation, migration, epithelial-to-mesenchymal transition and invasion in glioma cells. Various significant advancements in transcriptomic profiling studies have enabled the identification of immune-related long non-coding RNAs as immune cell-specific gene expression regulators that mediates both stimulatory and suppressive immune responses, implying lncRNAs as potential candidates for improving immunotherapy efficacy against tumors and due to the lack of different diagnostic and treatments for glioma, lncRNAs are potential candidates to be used as future diagnostic, prognostic biomarker and treatment tools for glioma. This review's primary purpose is to concentrate on the role of long non-coding RNAs in early glioma identification, treatment, and immunotherapy.

Citing Articles

Innovative perspectives on glioblastoma: the emerging role of long non-coding RNAs.

Doghish A, Mahmoud A, Abd-Elmawla M, Zaki M, Aborehab N, Hatawsh A Funct Integr Genomics. 2025; 25(1):43.

PMID: 39992471 DOI: 10.1007/s10142-025-01557-6.

New sights on long non-coding RNAs in glioblastoma: A review of molecular mechanism.

Bagheri-Mohammadi S, Karamivandishi A, Mahdavi S, Siahposht-Khachaki A Heliyon. 2024; 10(21):e39744.

PMID: 39553554 PMC: 11564028. DOI: 10.1016/j.heliyon.2024.e39744.

The pathogenesis mechanism and potential clinical value of lncRNA in gliomas.

Liu Y, Yuan H, Fan J, Wang H, Xie H, Wan J Discov Oncol. 2024; 15(1):266.

PMID: 38967893 PMC: 11226588. DOI: 10.1007/s12672-024-01144-4.

Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.

Jin X, Zhu J, Yu H, Shi S, Shen K, Gu J PLoS One. 2024; 19(3):e0298055.

PMID: 38530810 PMC: 10965094. DOI: 10.1371/journal.pone.0298055.

Role of Non-Coding RNAs in TGF-β Signalling in Glioma.

Shree B, Sharma V Brain Sci. 2023; 13(10).

PMID: 37891744 PMC: 10605910. DOI: 10.3390/brainsci13101376.

References

Zhao J, Xue J, Zhang W, Ren Y, Yan D . Long Noncoding RNA FGD5-AS1 Promotes Glioma Cell Proliferation, Migration and Invasion by Regulating wnt/β-Catenin Pathway. Cancer Manag Res. 2020; 12:6187-6193. PMC: 7398887. DOI: 10.2147/CMAR.S250284. View

Momtazmanesh S, Rezaei N . Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review. Front Oncol. 2021; 11:712786. PMC: 8311560. DOI: 10.3389/fonc.2021.712786. View

Zhou K, Zhang C, Yao H, Zhang X, Zhou Y, Che Y . Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132. Mol Cancer. 2018; 17(1):105. PMC: 6064054. DOI: 10.1186/s12943-018-0849-2. View

Ebrahimi A, Ashoori H, Vahidian F, Samiei Mosleh I, Kamian S . Long non-coding RNA panel as a molecular biomarker in glioma. J Egypt Natl Canc Inst. 2021; 33(1):31. DOI: 10.1186/s43046-021-00090-4. View

Louis D, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee W . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016; 131(6):803-20. DOI: 10.1007/s00401-016-1545-1. View

Zhang X, Niu W, Mu M, Hu S, Niu C . Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop. J Exp Clin Cancer Res. 2020; 39(1):196. PMC: 7510091. DOI: 10.1186/s13046-020-01695-8. View

Chen X, Zhu M, Wang S . Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance. Eur Rev Med Pharmacol Sci. 2019; 23(8):3455-3460. DOI: 10.26355/eurrev_201904_17710. View

Yang X, Xie Z, Lei X, Gan R . Long non-coding RNA GAS5 in human cancer. Oncol Lett. 2020; 20(3):2587-2594. PMC: 7400976. DOI: 10.3892/ol.2020.11809. View

Liu Z, Tian Y, Wu H, Ouyang S, Kuang W . LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis. Neoplasma. 2019; 67(1):111-118. DOI: 10.4149/neo_2019_190121N61. View

10.

Kim S, Harford J, Moghe M, Rait A, Pirollo K, Chang E . Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide. Nucleic Acids Res. 2017; 46(3):1424-1440. PMC: 5815062. DOI: 10.1093/nar/gkx1221. View

11.

Jin M, Jin W . The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020; 5(1):166. PMC: 7447642. DOI: 10.1038/s41392-020-00280-x. View

12.

Guo X, Zhong S, Wang Z, Xie T, Duan H, Zhang J . Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme. Front Genet. 2021; 12:633812. PMC: 8012670. DOI: 10.3389/fgene.2021.633812. View

13.

Liang Q, Li X, Guan G, Xu X, Chen C, Cheng P . Long non-coding RNA, HOTAIRM1, promotes glioma malignancy by forming a ceRNA network. Aging (Albany NY). 2019; 11(17):6805-6838. PMC: 6756894. DOI: 10.18632/aging.102205. View

14.

Peng L, Chen Z, Chen Y, Wang X, Tang N . MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers. Cancer Med. 2019; 8(17):7161-7173. PMC: 6885872. DOI: 10.1002/cam4.2583. View

15.

Tykocki T, Eltayeb M . Ten-year survival in glioblastoma. A systematic review. J Clin Neurosci. 2018; 54:7-13. DOI: 10.1016/j.jocn.2018.05.002. View

16.

Zhou L, Zhu Y, Sun D, Zhang Q . Emerging Roles of Long non-coding RNAs in The Tumor Microenvironment. Int J Biol Sci. 2020; 16(12):2094-2103. PMC: 7294937. DOI: 10.7150/ijbs.44420. View

17.

Zhang D, Jiang H, Ye J, Gao M, Wang X, Lu E . A novel lncRNA, RPL34-AS1, promotes proliferation and angiogenesis in glioma by regulating VEGFA. J Cancer. 2021; 12(20):6189-6197. PMC: 8425216. DOI: 10.7150/jca.59337. View

18.

Atianand M, Caffrey D, Fitzgerald K . Immunobiology of Long Noncoding RNAs. Annu Rev Immunol. 2017; 35:177-198. PMC: 6449690. DOI: 10.1146/annurev-immunol-041015-055459. View

19.

Liu G, Yang H, Cao L, Han K, Li G . LncRNA TMPO-AS1 Promotes Proliferation and Invasion by Sponging miR-383-5p in Glioma Cells. Cancer Manag Res. 2020; 12:12001-12009. PMC: 7696628. DOI: 10.2147/CMAR.S282539. View

20.

Yan Q, Zhu C, Guang S, Feng X . The Functions of Non-coding RNAs in rRNA Regulation. Front Genet. 2019; 10:290. PMC: 6463246. DOI: 10.3389/fgene.2019.00290. View